ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX
Delisted
ORTX was delisted on the 23rd of January, 2024.
61 hedge funds and large institutions have $38.9M invested in Orchard Therapeutics plc American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
-11
Holders Change %
-15.28%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
14
Reduced
16
Closed
18
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
+$104K
Top Buyers
| 1 |
SG Americas Securities
New York
|
+$287K |
| 2 |
BlackRock
New York
|
+$88.6K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$38.5K |
| 4 |
FA
Forefront Analytics
West Conshohocken,
Pennsylvania
|
+$34.1K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$25.2K |
Top Sellers
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$3.19M |
| 2 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$1.76M |
| 3 |
CA
CHI Advisors
New York
|
-$813K |
| 4 |
Two Sigma Investments
New York
|
-$716K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$477K |
